TickerFactsScreenerDevelopers

Cartesian Therapeutics, Inc. (RNAC) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2013: -$69.46M2014: -$87.75M2015: -$116.49M2016: $54.96M2017: $51.81M2018: -$5.42M2019: $8.40M2020: -$18.01M2021: $22.52M2022: $93.83M2023: -$440.18M2024: -$6.80M2025: -$126.24M-$126.24M
2013Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$126.24M-1755.9%
2024-$6.80M+98.5%
2023-$440.18M-569.1%
2022$93.83M+316.6%
2021$22.52M+225.1%
2020-$18.01M-314.4%
2019$8.40M+255.0%
2018-$5.42M-110.5%
2017$51.81M-5.7%
2016$54.96M+147.2%
2015-$116.49M-32.7%
2014-$87.75M-26.3%
2013-$69.46M—